The novel function of OCT4B Isoform-265 in genotoxic stress

Stem Cells

Volumn 30, Issue 4, 2012, Pages 665-672

  Gao, Yuan ^a   Wei, Jianshu ^a   Han, Jin ^a   Wang, Xia ^a   Su, Guannan ^a   Zhao, Yannan ^a   Chen, Bing ^a   Xiao, Zhifeng ^a   Cao, Jiani ^a   Dai, Jianwu ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Apoptosis; Genotoxic stress; Isoform; OCT4; p53; Stem cells

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; TRANSCRIPTION FACTOR OCT4B 265; UNCLASSIFIED DRUG;

ARTICLE; CELL STRESS; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; GENOTOXIC STRESS; GENOTOXICITY; HUMAN; HUMAN CELL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

EID: 84859494961     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1034     Document Type: Article

References (50)

1. Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391. (Pubitemid 28507326)
2. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376. (Pubitemid 30187435)
3. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956. (Pubitemid 41345211)
4. Hay DC, Sutherland L, Clark J et al. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004;22: 225-235. (Pubitemid 38282637)
5. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
6. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
7. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
8. Takeda J, Seino S, Bell GI. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 1992;20: 4613-4620.
9. Atlasi Y, Mowla SJ, Ziaee SA et al. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008;26:3068-3074.
10. Wang X, Zhao Y, Xiao Z et al. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells 2009;27:1265-1275.
11. Gao Y, Wang X, Han J et al. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. J Genet Genomics 2010;37:461-465.
12. Cauffman G, Van de Velde H, Liebaers I et al. Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod 2005;11:173-181. (Pubitemid 40662750)
13. Cauffman G, Liebaers I, Van Steirteghem A et al. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006;24:2685-2691. (Pubitemid 46053006)
14. Lee J, Kim HK, Rho JY et al. The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 2006;281: 33554-33565. (Pubitemid 46036736)
15. Abdel-Rahman B, Fiddler M, Rappolee D et al. Expression of transcription regulating genes in human preimplantation embryos. Hum Reprod (Oxford, England) 1995;10:2787-2792.
16. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404. (Pubitemid 30217526)
17. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 2000;6: 999-1004.
18. Richards M, Tan SP, Tan JH et al. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 2004; 22:51-64. (Pubitemid 38018781)
19. Matin MM, Walsh JR, Gokhale PJ et al. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 2004;22:659-668. (Pubitemid 39166924)
20. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39-85. (Pubitemid 39050363)
21. Wang X, Ohnishi T. p53-dependent signal transduction induced by stress. J Radiat Res 1997;38:179-194. (Pubitemid 127461818)
22. Amundson SA, Zhan Q, Penn LZ et al. Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents. Oncogene 1998;17:2149-2154. (Pubitemid 28515368)
23. Antoch MP, Kondratov RV. Circadian proteins and genotoxic stress response. Circ Res 2010;106:68-78.
24. Holzel M, Burger K, Muhl B et al. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: A double-edged sword. Oncotarget 2010;1:43-47.
25. Pluquet O, Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett 2001;174:1-15. (Pubitemid 33001303)
26. Saito S, Yamaguchi H, Higashimoto Y et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 2003;278:37536-37544. (Pubitemid 37175275)
27. He LF, Chen JG. DNA damage, apoptosis and cell cycle changes induced by fluoride in rat oral mucosal cells and hepatocytes. World J Gastroenterol 2006;12:1144-1148.
28. Canman CE, Chen CY, Lee MH, et al. DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis. Cold Spring Harb Symp Quant Biol 1994;59:277-286.
29. Goi K, Takagi M, Iwata S et al. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res 1997;57:1895-1902. (Pubitemid 27209718)
30. Fukasawa K, Wiener F, Vande Woude GF et al. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 1997;15:1295-1302. (Pubitemid 27429745)
31. Livingstone LR, White A, Sprouse J et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992;70:923-935.
32. Zhan Q, Carrier F, Fornace AJ, Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 1993;13: 4242-4250. (Pubitemid 23187653)
33. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993;8:307-318. (Pubitemid 23073746)
34. Bates S, Vousden KH. p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 1996;6:12-18. (Pubitemid 26059045)
35. Zhu Z, Wen J, Zheng X, et al. Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells. J Huazhong Univ Sci Technol Med Sci 2009; 29:73-76.
36. Xu K, Zhu Z, Zeng F. Expression and significance of Oct4 in bladder cancer. J Huazhong Univ Sci Technol Med Sci 2007;27: 675-677.
37. Tai MH, Chang CC, Kiupel M et al. Oct4 expression in adult human stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26:495-502.
38. Monsef N, Soller M, Isaksson M et al. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia. Prostate 2009;69:909-916.
39. Kotova N, Hemminki K, Segerback D. Urinary thymidine dimer as a marker of total body burden of UV-inflicted DNA damage in humans. Cancer Epidemiol Biomarkers Prev 2005;14:2868-2872. (Pubitemid 43068817)
40. Kolodner RD, Putnam CD, Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science 2002;297:552-557. (Pubitemid 34815331)
41. Zhou BB, Elledge SJ. The DNA damage response: Putting checkpoints in perspective. Nature 2000;408:433-439.
42. Kastan MB, Zhan Q, el-Deiry WS et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587-597.
43. Agarwal ML, Agarwal A, Taylor WR et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995;92:8493-8497.
44. Wells WA. The spindle-assembly checkpoint: Aiming for a perfect mitosis, every time. Trends Cell Biol 1996;6:228-234. (Pubitemid 26154850)
45. Zhang H, Somasundaram K, Peng Y et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 1998;16:1713-1721. (Pubitemid 28175052)
46. Chen IT, Smith ML, O'Connor PM et al. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA. Oncogene 1995;11:1931-1937.
47. Marin MC, Hsu B, Meyn RE et al. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 1994;9:3107-3112. (Pubitemid 24338437)
48. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
49. el-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
50. Zhan Q, Bae I, Kastan MB et al. The p53-dependent gamma-ray response of GADD45. Cancer Res 1994;54:2755-2760. (Pubitemid 2087873)